US pharma sales reps have

8 January 2007

The California Health Care Foundation, a non-profit organization which studies health care and drug-related issues, has reported that pharmaceutical sales representatives are increasingly rejected by physicians. The trend is linked to the adoption by the drug industry of guidelines which limit the distribution of gifts to physicians.

Eric Challgren, a dermatologist based in North Carolina, USA, told the Raleigh News & Observer newspaper that doctors are less likely to receive drug firm salesmen, as they no longer "have that carrot to dangle."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight